Illumina to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, 2024
SAN DIEGO, Jan. 4, 2024 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the fourth quarter and full year 2023 following the close of market on Thursday, February 8, 2024.
Related news for (ILMN)
- Illumina advances personalized cancer care with new pharma development partnerships
- Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025
- Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
- Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company’s multiomics strategy
- Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis